Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more
Inst Diagnosti (INDISA) - Total Liabilities
Latest total liabilities as of June 2025: CL$191.22 Billion CLP
Based on the latest financial reports, Inst Diagnosti (INDISA) has total liabilities worth CL$191.22 Billion CLP as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inst Diagnosti - Total Liabilities Trend (2014–2024)
This chart illustrates how Inst Diagnosti's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Inst Diagnosti Competitors by Total Liabilities
The table below lists competitors of Inst Diagnosti ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AGARWALEYE
NSE:AGARWALEYE
|
India | ₹17.67 Billion |
|
Xinlei Compressor Co. Ltd. A
SHE:301317
|
China | CN¥1.03 Billion |
|
Telecom Argentina S.A
PINK:TCMFF
|
USA | $9.09 Trillion |
|
DongKook Pharmaceutical Co. Ltd
KQ:086450
|
Korea | ₩293.92 Billion |
|
Jiangsu Jiuwu Hi-Tech Co Ltd
SHE:300631
|
China | CN¥678.61 Million |
|
Qingdao Daneng Environmental Protection Equipment Co Ltd
SHG:688501
|
China | CN¥1.73 Billion |
|
BOE Varitronix Limited
PINK:VARXF
|
USA | $7.12 Billion |
|
Black Diamond Group Limited
OTCQX:BDIMF
|
USA | $439.32 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Inst Diagnosti's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inst Diagnosti's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inst Diagnosti (2014–2024)
The table below shows the annual total liabilities of Inst Diagnosti from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CL$163.28 Billion | -5.38% |
| 2023-12-31 | CL$172.56 Billion | +0.75% |
| 2022-12-31 | CL$171.26 Billion | +26.20% |
| 2021-12-31 | CL$135.71 Billion | +38.62% |
| 2020-12-31 | CL$97.90 Billion | +13.08% |
| 2019-12-31 | CL$86.58 Billion | -0.96% |
| 2018-12-31 | CL$87.42 Billion | -3.79% |
| 2017-12-31 | CL$90.86 Billion | -0.33% |
| 2016-12-31 | CL$91.16 Billion | +15.85% |
| 2015-12-31 | CL$78.69 Billion | +27.89% |
| 2014-12-31 | CL$61.53 Billion | -- |